Dkiru LLC is recalling its Adndale Magnesium Glycinate Gummies 400 mg after the product was found to contain melatonin that was never listed on the label. The recall appeared in the latest food alerts roundup from the Texas Department of State Health Services, catching a labeling failure that federal enforcement channels had not yet classified. For anyone who bought these gummies expecting a simple magnesium supplement, the hidden hormone raises real health concerns, especially for children and people sensitive to melatonin’s effects on sleep cycles and endocrine function.
How undeclared melatonin in Adndale gummies reached store shelves
The recall centers on a specific product: Adndale Magnesium Glycinate Gummies labeled at 400 mg, manufactured or distributed by Dkiru LLC. According to the Texas DSHS food alerts list, the gummies contain undeclared melatonin, a substance that acts as a hormone regulating the body’s sleep-wake cycle. Melatonin is not an inert filler. Even small amounts can cause drowsiness, headaches, and hormonal disruption, and its presence in a product marketed purely as a mineral supplement means consumers had no way to account for it.
State-level recall listings like the one maintained by Texas DSHS often surface these cases before the FDA’s own weekly Enforcement Report catches up. The FDA publishes recall entries through its Enforcement Reports database, but entries can remain “not yet classified” for weeks after a state agency has already posted the alert. That gap matters because it means consumers in other states may not see a federal warning until well after the product has been flagged at the state level. Texas DSHS, which tests retail samples independently, effectively bypassed the slower federal import-screening pipeline in this case.
Dkiru LLC has not issued a public statement explaining how melatonin ended up in a magnesium product. No certificate of analysis or lab report quantifying the actual melatonin content per gummy has been released by either the company or regulators. That silence leaves a basic question unanswered: was this a manufacturing mix-up at a shared production facility, a deliberate but undisclosed formulation choice, or contamination from a supplier?
Without those details, it is also unclear whether the problem is limited to a specific lot or production date, or whether the formulation has included melatonin from the outset. The Texas listing identifies the product and the undeclared ingredient but does not spell out the full distribution history. That lack of transparency complicates efforts by retailers and consumers to trace which bottles are affected and whether any supposedly “safe” batches exist.
Melatonin mislabeling is a wider pattern, not an isolated mistake
The Adndale recall fits a broader pattern of melatonin showing up where it should not, or in wildly inaccurate amounts. Australia’s Therapeutic Goods Administration has documented imported melatonin products that contained more than four times the stated dose, while other products tested by the same agency contained no melatonin at all. That kind of variability turns dosing into guesswork and creates particular risks for children, whose smaller body weight amplifies the effect of any unexpected hormone exposure.
In the United States, melatonin is widely available in gummies, liquids, and tablets, often marketed with child-friendly packaging and flavors. Yet studies and regulatory spot checks have repeatedly found large discrepancies between labeled and actual melatonin content. When a product such as Adndale’s magnesium gummies adds melatonin without declaring it, those dosing uncertainties become even more dangerous, because families may be layering the hidden hormone on top of a separate, intentionally purchased melatonin supplement.
Melatonin occupies an unusual regulatory space in the United States. It is sold over the counter as a dietary supplement rather than a prescription drug, which means it faces less pre-market scrutiny than pharmaceuticals. But “less scrutiny” does not mean “no rules.” A supplement that contains an ingredient not declared on its label violates federal labeling requirements regardless of whether that ingredient is legal to sell separately. The distinction is about informed consent: a parent giving a child a magnesium gummy at breakfast has a right to know whether that gummy also contains a sleep-inducing hormone.
The FDA also maintains a health fraud product database cataloging items with undisclosed active compounds, from weight-loss pills to sexual-enhancement products. While melatonin itself is not an illegal substance, the enforcement logic is similar: when a supplement contains an active ingredient that is not on the label, the consumer loses the ability to make an informed choice about what they are putting in their body. That erosion of trust can spill over to the broader supplement market, making it harder for reputable brands to reassure cautious buyers.
What buyers of Adndale gummies should do now
Several pieces of information are still missing from the public record. No adverse-event reports tied specifically to this lot have appeared in either Texas DSHS records or federal databases. No FDA recall classification, which would indicate the severity of the health risk on a scale from Class I (most serious) to Class III (least serious), has been assigned. And no termination date for the recall has been posted, meaning it is unclear how long the affected product was on the market or how many units were sold.
The absence of a company explanation is the most conspicuous gap. Without knowing the root cause, consumers cannot assess whether other Dkiru LLC products might carry similar risks. A manufacturing cross-contamination issue at a contract facility, for instance, could affect multiple product lines, not just the Adndale magnesium gummies. Until more is known, cautious consumers may reasonably decide to pause use of other supplements from the same firm or to contact retailers for clarification.
Anyone who purchased Adndale Magnesium Glycinate Gummies 400 mg should stop using the product immediately and check the bottle for any recall or lot information that matches the Texas DSHS alert. Even in the absence of reported injuries, the presence of an undeclared hormone is enough reason to discontinue use, especially for children, pregnant or breastfeeding people, older adults, and anyone taking medications that interact with sedating agents. Consumers can ask the store where they purchased the gummies about return or refund options; many retailers cooperate with recalls even when a formal federal classification is still pending.
People who have already consumed the gummies should watch for signs of unexpected drowsiness, changes in sleep patterns, headaches, or mood shifts. While most healthy adults tolerate typical melatonin doses without serious harm, unplanned exposure can still interfere with work, driving, or school performance. Parents who notice unusual sleepiness or behavioral changes in children who took the product should contact a pediatrician or local poison control center for guidance, especially if the child is also on other medications.
Healthcare providers may want to ask patients about their use of magnesium supplements and gummies more broadly, not just products explicitly labeled as melatonin. Because undeclared ingredients are, by definition, invisible on the label, clinicians often have to rely on detailed histories and recall notices to identify possible sources of unexplained symptoms like daytime fatigue or disrupted circadian rhythms.
For now, the Adndale case highlights the value of monitoring both state and federal recall channels. Consumers, clinicians, and retailers who depend solely on national databases may miss important early warnings that appear first at the state level. Until Dkiru LLC and federal regulators provide more detailed answers, the safest course for anyone with a bottle of these magnesium gummies is to set it aside, seek a refund if possible, and choose an alternative supplement from a manufacturer that can document exactly what is-and is not-in each dose.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
